Perioperative Research Into Memory: Cognitive Outcome Following Major Burns

Overview

The long term survival of patients who require admission to critical care (CC) following a major burn injury (MBI) continues to improve with advanced clinical management. There has been increasing interest into cognitive dysfunction (CD) due to neuroinflammation (NI) following CC, anaesthesia, surgery, and the association of NI with diseases characterised by CD such as Alzheimer's disease. Patients who suffer a MBI and who subsequently require admission to CC will be at uniquely high risk for CD. MBI produces an exaggerated and prolonged systemic inflammatory response, with NI demonstrated in animal models. Additionally NI can be exaggerated by insults such as sepsis, anaesthesia, and surgical trauma, common and often necessary following MBI. The aim of this study is to identify CD using cognitive tests to examine for deficits in working memory and executive function. Test proposed to use are the Hopkins Verbal Learning and Verbal Fluency tests, and a validated computerised battery (CogState). Neuroinflammation and underlying pathophysiology using fMRI and spectroscopy, known to demonstrate biomarkers for CD and NI. QoL will be assessed using the validated EQ-5D tool. The Inclusion criteria; patients who survive their burns injury (greater than 15% total body surface area) and require mechanical ventilation. Primary exclusion criteria; admission with toxic epidermal necrolysis syndrome, and evidence of head trauma.

Full Title of Study: “Using Cognitive Tests and Functional MRI to Investigate Long Term Cognitive Dysfunction Following a Critical Illness Due to a Major Burn Injury”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 30, 2016

Detailed Description

This is a novel, proof of principle, prospective, cohort design, observational clinical study to assess for functional brain reorganisation, structural changes and long-term cognitive dysfunction following major burns injury and intensive care admission. The hypothesis is that following a major burns injury and intensive care admission patients will have neurocognitive dysfunction and demonstrable functional alterations seen on functional MRI due to neuroinflammation as a result of the primary injury and subsequent inflammatory insults.

Interventions

  • Behavioral: Face-to-face neurocognitive tests
    • Assessment of attention, processing speed, working memory and executive function
  • Behavioral: Psychological screening
    • Screening for the symptoms of depression, anxiety and post-traumatic stress disorder
  • Other: fMRI
    • Brain volume, chemical markers, functional outcome
  • Behavioral: Quality of Life Self-Assessment data
    • EQ-5D will be converted into a utility score using standard EQ-5D UK tariffs

Arms, Groups and Cohorts

  • 5-10 years post severe burn injury
    • Interventions: Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function. Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire. fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL. Quality of Life Self-Assessment data.
  • 2-5 years post severe burn injury
    • Interventions: Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function. Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire. fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL. Quality of Life Self-Assessment data.
  • 1-2 years post severe burn injury
    • Interventions: Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function. Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire. fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL. Quality of Life Self-Assessment data.
  • Control
    • Healthy age, gender, socioeconomic and educational level matched control. Interventions: Face-to-face neurocognitive tests examining attention, processing speed, working memory and executive function. Psychological screening for the symptoms of depression, anxiety and post-traumatic stress disorder using the patient health questionnaire (PHQ9), generalised anxiety (GAD7) scoring systems and the trauma screening questionnaire. fMRI studies including resting state fMRI, T1w-mpr, T2w-FLAIR, Diffusion Tensor Imaging (DTI) with 30 directions, Spectroscopy CSI chemical shift imaging, Spectroscopy SVS single voxel, susceptibility weighted imaging (SWI), double inversion recovery (DIR) and Perfusion ASL. Quality of Life Self-Assessment data.

Clinical Trial Outcome Measures

Primary Measures

  • Neurocognitive function
    • Time Frame: 5 years
    • Specifically to investigate cognitive tasks using a battery of computerised tests.

Secondary Measures

  • Neuroinflammatory changes analysis.
    • Time Frame: 5 years
    • Functional MRI scan

Participating in This Clinical Trial

Inclusion Criteria

  • Survival following admission to Chelsea and Westminster Burns Intensive Care Unit between 2004-2013 with a burn injury > 15% total body surface area, requiring intubation and ventilation Exclusion Criteria:

  • Patients under 16. – Patients with toxic epidermal necrolysis syndrome or evidence of head trauma. – Patients with evidence of risk to psychological safety from inclusion in study: any patient currently held under section of the Mental Health Act, any patient receiving formal psychiatric treatment (including involvement in a Personality Disorder Unit, being under voluntary section, current re-occurrence of chronic self harm), any patient currently detained at her Majesty's pleasure, any current substance abuse, or at the discretion of professional opinion following historical assessment of notes. - Patients with contraindications to MRI (patients with non-compatible pacemakers, patients with metallic foreign bodies e.g. metal sliver in their eye, patients with non-compatible surgical metal work, patients with severe claustrophobia). – Patient refusal or inability to give full informed consent. – Patients unable to understand plain verbal or written English.

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Chelsea and Westminster NHS Foundation Trust
  • Collaborator
    • Imperial College Healthcare NHS Trust
  • Provider of Information About this Clinical Study
    • Principal Investigator: Marcela P. Vizcaychipi, Planned Care Surgery & Clinical Support Divisional Research Lead – Chelsea and Westminster NHS Foundation Trust
  • Overall Official(s)
    • Marcela Vizcaychipi, MD PhD FRCA, Study Chair, Chelsea and Westminster Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.